The mechanism of bradycardia evoked by physical training.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 5596760)

Published in Cardiologia on January 01, 1967

Authors

M H Frick, R O Elovainio, T Somer

Articles by these authors

Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation (1992) 4.96

Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) (1984) 3.62

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89

Measurement of the angina threshold using atrial pacing. A new technique for the study of angina pectoris. Cardiovasc Res (1967) 2.84

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care (1992) 1.75

Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.70

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66

Relationship of skeletal muscle fiber type to serum high density lipoprotein cholesterol and apolipoprotein A-I levels. Atherosclerosis (1991) 1.56

Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet (1974) 1.54

Combined parasympathetic and beta-receptor blockade as a clinical test. Acta Med Scand (1967) 1.51

Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. A validation study. Int J Card Imaging (1994) 1.39

Fibrillar protein deposits with tubular substructure in a systemic disease beginning as cutis laxa. Arch Dermatol (1993) 1.38

The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J Intern Med (1994) 1.20

A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension. Br J Clin Pharmacol (1986) 1.13

The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up. J Intern Med (1994) 1.09

Rheumatoid factor and immuno-conglutinin responses following various vaccinations. Proc Soc Exp Biol Med (1967) 1.08

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest (1996) 1.06

Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol (1983) 1.04

Serum ceruloplasmin concentration in rheumatoid arthritis, ankylosing spondylitis, psoriasis and sarcoidosis. Acta Rheumatol Scand (1966) 1.03

The viscosity of blood, plasma and serum in dys- and paraproteinemias. Acta Med Scand Suppl (1966) 1.03

Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J (1994) 1.00

Malignancy in association with polymyalgia rheumatica and temporal arteritis. Scand J Rheumatol (1974) 0.99

Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension. Br Med J (1976) 0.99

Patency of sequential versus single vein grafts in coronary bypass surgery. Thorac Cardiovasc Surg (1982) 0.98

Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet (1989) 0.98

Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery. J Cardiovasc Surg (Torino) (1981) 0.96

Ultrasonic measurements of left ventricular wall thickness. Chest (1970) 0.96

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis (1998) 0.95

Regional myocardial perfusion abnormalities on xenon-133 imaging in patients with angina pectoris and normal coronary arteries. Am J Cardiol (1977) 0.93

Studies of false positive serological tests for syphilis following smallpox vaccination. Ann Med Exp Biol Fenn (1966) 0.92

Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis (1994) 0.92

Genetic variation in serum low density lipoproteins and lipid levels in man. Proc Natl Acad Sci U S A (1976) 0.92

Serum lipids in angiographically assessed coronary atherosclerosis. Chest (1978) 0.92

Changes in native coronary arteries after coronary bypass surgery. Role of graft patency, serum lipids and hypertension. Am J Cardiol (1975) 0.91

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. J Clin Invest (1998) 0.90

Survival with total occlusion of the left main coronary artery. Significance of the collateral circulation. Cathet Cardiovasc Diagn (1979) 0.90

9-alpha-fluorohydrocortisone in the treatment of postural hypotension. Acta Med Scand (1966) 0.89

Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol. Ann Clin Res (1978) 0.89

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. Atherosclerosis (2001) 0.89

Once daily versus twice daily beta-blockers: effects on arrhythmias and hypertension. Lancet (1980) 0.87

Effect of aorto-coronary grafts and native vessel patency on the occurrence of angina pectoris after coronary bypass surgery. Br Heart J (1975) 0.86

Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol (1991) 0.86

Analysis of coronary collaterals in ischaemic heart disease by angiography during pacing induced ischaemia. Br Heart J (1976) 0.86

Combined dihydralazine and propranolol in the treatment of hypertension. Int Z Klin Pharmakol Ther Toxikol (1970) 0.85

A clinical approach to systemic vasculitis. Semin Arthritis Rheum (1980) 0.85

The Helsinki Heart Study: basic design and randomization procedure. Eur Heart J (1987) 0.85

Seasonal variation in high density lipoprotein cholesterol. Atherosclerosis (1993) 0.84

Persistent improvement after coronary bypass surgery: ergometric and angiographic correlations at 5 years. Circulation (1983) 0.84

Insufficient cardiorespiratory response to exercise secondary to central nervous system lesions. Acta Med Scand (1966) 0.84

Detailed anatomy of the antebrachiocarpal joint in dogs. Anat Rec (1992) 0.84

Lp(a) lipoprotein/pre-beta1-lipoprotein, serum lipids and atherosclerotic disease. Clin Genet (1976) 0.83

Rheology of paraproteinaemias and the plasma hyperviscosity syndrome. Baillieres Clin Haematol (1987) 0.83

Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study Group. Eur Heart J (1994) 0.83

Isolated dislocation of the carpal scaphoid: two case reports. J Trauma (1994) 0.82

Angiographic findings in patients exhibiting ischemia after oral dipyridamole. Int J Cardiol (1989) 0.82

Supravalvular pulmonic stenosis, abnormal facial appearance, and mental retardation. Am Heart J (1968) 0.82

Aneurysm of the descending thoracic aorta, amyloidosis and renal carcinoma in a patient with ankylosing spondylitis. Am J Med (1970) 0.81

Sequential internal mammary artery (IMA) grafts in coronary artery bypass surgery. Thorac Cardiovasc Surg (1984) 0.81

Direct hospital costs in coronary bypass surgery. Ann Chir Gynaecol (1985) 0.81

Work status after coronary bypass surgery. A prospective randomized study with ergometric and angiographic correlations. Acta Med Scand (1979) 0.81

An appraisal of symptom relief after coronary bypass grafting. Postgrad Med J (1976) 0.80

Assessment of the effect of long-term dipyridamole in angina pectoris by atrial pacing and physical exercise. Ann Clin Res (1971) 0.79

The Helsinki Heart Study: central findings and clinical implications. Ann Med (1991) 0.79

Histologic structure of the articular disk of the human distal radioulnar joint. Clin Orthop Relat Res (1992) 0.79

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol. Circulation (1998) 0.79

Letter: Serum-H.D.L. in a therosclerotic heart-disease. Lancet (1976) 0.79

Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. Am J Cardiol (1989) 0.79

Amyloid-associated muscle pseudohypertrophy and multiple myeloma in a man with hypernephroma. Acta Med Scand (1983) 0.79

The effect of dipyridamole and warfarin on the patency rate of coronary artery bypass grafts. Thorac Cardiovasc Surg (1983) 0.79

Cigarette smoking is associated with elevated adrenal androgen response to adrenocorticotropin. J Steroid Biochem Mol Biol (1993) 0.79

On the aggregation of red cells in Waldenström's macroglobulinaemia and multiple myeloma. Microvasc Res (1975) 0.78

Cardiovascular dimensions and moderate physical training in young men. J Appl Physiol (1970) 0.78

Long-term excess physical activity and central haemodynamics in man. Adv Cardiol (1976) 0.78

Persistence of improved exercise tolerance and degree of revascularization after coronary bypass surgery. A prospective randomized study. Clin Cardiol (1979) 0.78

Efficacy of conventional and sustained-release verapamil in stable angina pectoris. Ann Med (1992) 0.78

Modification of digitalis-induced electrocardiographic changes by propranolol and potassium. Ann Clin Res (1972) 0.78

A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial. Control Clin Trials (1997) 0.77

Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris. Ann Clin Res (1976) 0.77

Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy. Thromb Haemost (2000) 0.77

A new electrical equipment for handgrip testing. Ann Clin Res (1979) 0.77

Prevention of deep venous thrombosis and thrombo-embolism by dipyridamole and acetylsalicylic acid after reconstructive arterial surgery. J Cardiovasc Surg (Torino) (1980) 0.77

Leukocytes as a coronary risk factor in a dyslipidemic male population. Am Heart J (1992) 0.77

Is the meniscus of the knee joint a fibrocartilage? Acta Anat (Basel) (1983) 0.76

Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels. Atherosclerosis (1990) 0.76

Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study. Br Heart J (1986) 0.75

Hemoglobin and packed-cell volume in endurance athletes prior to rhEPO. Int J Sports Med (2000) 0.75

Lipoproteins and coronary heart disease in the Helsinki Heart Study. Eur Heart J (1990) 0.75

Carditis associated with coronavirus infection. Lancet (1980) 0.75

Efficiency of a pacemaker clinic to prevent sudden pacing failures. Br Heart J (1973) 0.75

Effect of cardioselective beta-blockade by metoprolol on the phasic myocardial blood content and epi/endocardial ratio. Ann Clin Res (1977) 0.75

Open valvotomy for congenital valvular aortic stenosis in young adults. A hemodynamic follow-up study. G Ital Cardiol (1973) 0.75

Regional myocardial perfusion during ischemia. Circulation (1977) 0.75

Right atrial pacing in coronary heart disease. Adv Cardiol (1973) 0.75

Rapidity of the hypotensive effect of short-acting nitrous compounds. Ann Clin Res (1969) 0.75

[Drug therapy of angina pectoris]. Duodecim (1972) 0.75

Response of left ventricular myocardial perfusion and cavity size to beta-blockade by acebutolol. Ann Clin Res (1978) 0.75

Acromegaly and the heart. Circulation (1978) 0.75

The response of heart volume and ventricular functions to physical training in coronary heart disease. Mal Cardiovasc (1969) 0.75